These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11152317)

  • 1. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual.
    Cassinotti P; Siegl G
    Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):886-7. PubMed ID: 11152317
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of parvovirus B19 infection with glomerulonephritis in an immunocompetent host: a case report.
    Obeid KM; Effendi AR; Khatib R
    Scand J Infect Dis; 2009; 41(11-12):890-2. PubMed ID: 19922076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.
    Lefrère JJ; Servant-Delmas A; Candotti D; Mariotti M; Thomas I; Brossard Y; Lefrère F; Girot R; Allain JP; Laperche S
    Blood; 2005 Oct; 106(8):2890-5. PubMed ID: 15976179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
    Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
    Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections.
    Harder TC; Hufnagel M; Zahn K; Beutel K; Schmitt HJ; Ullmann U; Rautenberg P
    J Clin Microbiol; 2001 Dec; 39(12):4413-9. PubMed ID: 11724854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
    Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
    J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal involvement of human parvovirus B19 in an immunocompetent host.
    Taylor G; Drachenberg C; Faris-Young S
    Clin Infect Dis; 2001 Jan; 32(1):167-9. PubMed ID: 11106317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients.
    Gallinella G; Manaresi E; Venturoli S; Grazi GL; Musiani M; Zerbini M
    Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):811-3. PubMed ID: 10614957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory.
    Manaresi E; Gallinella G; Zuffi E; Bonvicini F; Zerbini M; Musiani M
    J Med Virol; 2002 Jun; 67(2):275-81. PubMed ID: 11992590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute encephalopathy with human parvovirus B19 infection in hereditary spherocytosis.
    Oshima K; Kikuchi A; Mochizuki S; Arai T; Oishi T; Hanada R
    Pediatr Infect Dis J; 2008 Jul; 27(7):651-2. PubMed ID: 18520445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serious parvovirus B19 genotype 2 infection not detected in a commercial PCR assay.
    Modi SL; Firnhaber C; Kana V; Skhosana L; Carmona S; Rossouw I
    J Clin Virol; 2014 May; 60(1):70-2. PubMed ID: 24589313
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients.
    Siritantikorn S; Kaewrawang S; Siritanaratkul N; Theamboonlers A; Poovorawan Y; Kantakamalakul W; Wasi C
    Asian Pac J Allergy Immunol; 2007; 25(2-3):169-74. PubMed ID: 18035805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA.
    Aberham C; Pendl C; Gross P; Zerlauth G; Gessner M
    J Virol Methods; 2001 Apr; 92(2):183-91. PubMed ID: 11226565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
    Baylis SA; Shah N; Minor PD
    J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible parvovirus B19 encephalitis in an immunocompetent adult patient.
    Tonnellier M; Bessereau J; Carbonnell N; Guidet B; Méritet JF; Kerr JR; Monnier-Cholley L; Offenstadt G; Maury E
    J Clin Virol; 2007 Feb; 38(2):186-7. PubMed ID: 17174596
    [No Abstract]   [Full Text] [Related]  

  • 17. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
    Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
    J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders.
    Lundqvist A; Tolfvenstam T; Brytting M; Stolt CM; Hedman K; Broliden K
    Scand J Infect Dis; 1999; 31(2):119-22. PubMed ID: 10447317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
    Cassinotti P; Siegl G; Michel BA; Brühlmann P
    J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient.
    Cassinotti P; Schultze D; Schlageter P; Chevili S; Siegl G
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):701-4. PubMed ID: 8243488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.